Prices as of 2026-06-05 16:20:43 ET
Ticker Appearances
Live Technical Stock Analysis
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
March likely to be better than average given prior 4 months having turned in positive performance
EQUITY TRENDS SHOW NO EVIDENCE OF WAVERING. FEBRUARY MANAGED TO FINISH WITH GAINS GREATER THAN 5% ON THE HEELS OF THREE PRIOR MONTHS OF GAINS,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Japan’s NKY breaks out, while US Semiconductors & Homebuilders weaken
US EQUITY INDICES AND TREASURY YIELDS REMAIN QUITE CHOPPY, BUT THE WEAKNESS COINCIDING WITH YIELDS PUSHING UP STILL LOOKS TO EXTEND INTO NEXT WEEK. TRENDS...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Natural Gas & NIKKEI both look appealing for gains
The persistent melt-up for US Equities has been far more resilient than I expected to end the week, showing little to no evidence of turning...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotech bounce a welcome development for Healthcare
Sideways consolidation still ongoing for US equities and no real technical takeawayDollar/Yen rally could bring about Japanese Equity outperformanceBiotech bounce is a positive for Healthcare...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
March likely to be better than average given prior 4 months having turned in positive performance
EQUITY TRENDS SHOW NO EVIDENCE OF WAVERING. FEBRUARY MANAGED TO FINISH WITH GAINS GREATER THAN 5% ON THE HEELS OF THREE PRIOR MONTHS OF GAINS,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Japan’s NKY breaks out, while US Semiconductors & Homebuilders weaken
US EQUITY INDICES AND TREASURY YIELDS REMAIN QUITE CHOPPY, BUT THE WEAKNESS COINCIDING WITH YIELDS PUSHING UP STILL LOOKS TO EXTEND INTO NEXT WEEK. TRENDS...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Natural Gas & NIKKEI both look appealing for gains
The persistent melt-up for US Equities has been far more resilient than I expected to end the week, showing little to no evidence of turning...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Biotech bounce a welcome development for Healthcare
Sideways consolidation still ongoing for US equities and no real technical takeawayDollar/Yen rally could bring about Japanese Equity outperformanceBiotech bounce is a positive for Healthcare...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 3 [max_usage] => 2 [max_usage_crypto] => 2 )
